Stalevo Interactions
There are 533 drugs known to interact with Stalevo (carbidopa/entacapone/levodopa), along with 14 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 50 are major, 471 are moderate, and 12 are minor.
- View all 533 medications that may interact with Stalevo
- View Stalevo alcohol/food interactions (2)
- View Stalevo disease interactions (14)
Most frequently checked interactions
View interaction reports for Stalevo (carbidopa / entacapone / levodopa) and the medicines listed below.
- amantadine
- amlodipine
- Aricept (donepezil)
- aspirin
- Azilect (rasagiline)
- carbidopa / levodopa
- Celebrex (celecoxib)
- clonazepam
- furosemide
- gabapentin
- hydrochlorothiazide
- levothyroxine
- lisinopril
- lorazepam
- Lyrica (pregabalin)
- metformin
- Mirapex (pramipexole)
- omeprazole
- Paracetamol (acetaminophen)
- Plavix (clopidogrel)
- pramipexole
- Requip (ropinirole)
- selegiline
- Seroquel (quetiapine)
- simvastatin
- Sinemet (carbidopa / levodopa)
- Synthroid (levothyroxine)
- tamsulosin
- tramadol
- Vitamin D3 (cholecalciferol)
Stalevo alcohol/food interactions
There are 2 alcohol/food interactions with Stalevo (carbidopa / entacapone / levodopa).
Stalevo disease interactions
There are 14 disease interactions with Stalevo (carbidopa / entacapone / levodopa) which include:
- glaucoma
- cardiac disease
- neuroleptic malignant syndrome
- psychoses/depression
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- depression
- sleep disorders
- hypotension
- psychosis
- hepatic impairment
- GI bleeding
Report options
More about Stalevo (carbidopa / entacapone / levodopa)
- Stalevo consumer information
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: dopaminergic antiparkinsonism agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.